Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Baker Hughes Co (BKR) vs Moderna, Inc. (MRNA) Price & Performance

Baker Hughes CoTrade
Moderna, Inc.Trade

Price performance (Past 24H)

Key statistics

Baker Hughes Co vs Moderna, Inc. — how do they compare? Baker Hughes Co trades at $64.83 (market cap $63.60B), while Moderna, Inc. trades at $60.83 (market cap $23.88B). The key difference: Baker Hughes Co is far larger — about 2.7× Moderna, Inc.'s market cap, and Baker Hughes Co pays a 1.44% dividend while Moderna, Inc. pays none. Which is the better fit depends on your goals.

BKRMRNA
Market Cap
$63.60B$23.88B
Sector
EnergyHealth
52-Week High
$69.67$81.80
52-Week Low
$42.51$22.36
Enterprise Value
$64.13B$20.03B
Dividend Yield
1.44%

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

About Baker Hughes Co

Baker Hughes is a global leader in oilfield services and oilfield equipment, with particularly strong presences in the artificial lift, specialty chemicals, and completions markets. The other half of its business focuses on industrial power generation, process solutions, and industrial asset management, with high exposure to the liquid natural gas market specifically, as well as broader industrials end markets.

Read more on BKR

About Moderna, Inc.

Moderna, Inc. operates as a clinical stage biotechnology company. The Company focuses on the discovery and development of messenger RNA (mRNA) therapeutics and vaccines. Moderna develops mRNA medicines for infectious, immuno-oncology, and cardiovascular diseases.

Read more on MRNA